GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » EV-to-EBITDA

Probiotix Health (AQSE:PBX) EV-to-EBITDA : -6.48 (As of May. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Probiotix Health's enterprise value is £3.14 Mil. Probiotix Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.48 Mil. Therefore, Probiotix Health's EV-to-EBITDA for today is -6.48.

The historical rank and industry rank for Probiotix Health's EV-to-EBITDA or its related term are showing as below:

AQSE:PBX' s EV-to-EBITDA Range Over the Past 10 Years
Min: -6.48   Med: 125.58   Max: 356.6
Current: -6.48

During the past 4 years, the highest EV-to-EBITDA of Probiotix Health was 356.60. The lowest was -6.48. And the median was 125.58.

AQSE:PBX's EV-to-EBITDA is ranked worse than
100% of 462 companies
in the Biotechnology industry
Industry Median: 9.49 vs AQSE:PBX: -6.48

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-11), Probiotix Health's stock price is £0.0425. Probiotix Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.004. Therefore, Probiotix Health's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Probiotix Health EV-to-EBITDA Historical Data

The historical data trend for Probiotix Health's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health EV-to-EBITDA Chart

Probiotix Health Annual Data
Trend Dec18 Dec19 Dec20 Dec22
EV-to-EBITDA
- - - -

Probiotix Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23
EV-to-EBITDA Get a 7-Day Free Trial - - - - -

Competitive Comparison of Probiotix Health's EV-to-EBITDA

For the Biotechnology subindustry, Probiotix Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Probiotix Health's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Probiotix Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Probiotix Health's EV-to-EBITDA falls into.



Probiotix Health EV-to-EBITDA Calculation

Probiotix Health's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3.136/-0.484
=-6.48

Probiotix Health's current Enterprise Value is £3.14 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Probiotix Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Probiotix Health  (AQSE:PBX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Probiotix Health's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0425/-0.004
=At Loss

Probiotix Health's share price for today is £0.0425.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Probiotix Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Probiotix Health EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Probiotix Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Probiotix Health (AQSE:PBX) Business Description

Traded in Other Exchanges
Address
Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB
Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines